Sign in

Farah Wehbe

@farahwehbe92.bsky.social
33 followers 47 following 6 posts
PostsRepliesMedia
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 30/09/2026
9/10 I want more info: nephjc.com/news/startst... www.nephjc.com/news/starttr... www.nephjc.com/news/startsp... Andreea Manolea, Farah Wehbe, David White
nephjc.com
Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
101
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 30/09/2026
1/10 #NephJC #TenPosts #NephSly 🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵 www.sciencedirect.com/science/arti...
sciencedirect.com
155
Farah Wehbe @farahwehbe92.bsky.social · 30/09/2026
A nephrologist’s #WorldHeartDay reminder: the heart and kidneys are in a lifelong group chat. ❤️🫘 When one is struggling, the other usually gets the message. Protect one, and you often protect the other.
000
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 28/09/2026
Hey #NephJC 👋 Checkout the VA by @divyaveerssneph.bsky.social This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS). 💊Steroids: easy to start🟢 but hard to stop 🛑. #NephSky www.nephjc.com/news/starttrial
nephjc.com
START: The Visual Abstract — NephJC
Can steroid tapering be shorter after remission in adults with sensitive podocytopathy?
089
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 28/09/2026
Steroids are useful (and have bad side effects) in patients with podocytopathies. Starting is easy, but stopping can be challenging. Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢 #NephSky #NephJC www.nephjc.com/news/startsteroidtaper
nephjc.com
Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
076
Farah Wehbe @farahwehbe92.bsky.social · 28/09/2026
A very practical question in podocytopathy: how soon can we taper steroids without paying for it with more relapses? 🐇🐢 Enjoy reading! 👇🏻 #START trial #NephJC #NephSky
010
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 15/09/2026
📣Hey #NephSky We just passed 5000 #NephJC Newsletter subscribers Will you be 5001? Also, we can now be found at LinkedIN. So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well! www.nephjc.com/news/nephjc-on-linkedin
nephjc.com
NephJC on LinkedIn — NephJC
NephJC is now more than twelve years old- and it’s amazing to see how far a simple idea has grown. We started with a handful of nephrologists on Twitter (yeah, we still call it that) choosing a paper ...
074
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 19/08/2026
1/10 #NephJC #TenPostNephJC #NephSky Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊 Read the article 👇 pubmed.ncbi.nlm.nih.gov/42530910/
255
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 17/07/2026
🔍FIND-CKD🔎 💊Use of finerenone in non-diabetic CKD #NephJC #NephSky #ERA26 VA by @drbarbateba.bsky.social www.nephjc.com/news/2026/7/17/find-ckd-the-visual-abstract
nephjc.com
FIND CKD: The Visual Abstract — NephJC
Is finerenone ready to move beyond diabetes? The FIND-CKD phase 3 arrived from the #ERA26 and is the first one to show kidney protection with finerenone in non-diabetic CKD. The next challenge is no...
085
Reposted by Farah Wehbe
Nephrology Journal Club @nephjc.bsky.social · 28/06/2026
🦵Had our Kick-off meeting today to welcome a new class of #NephJC interns (year 12 and counting). 👁️Keep an eye out for new blog and VA creators. See if you can Catch'em All🎣 #NephSky #MedSky @hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
088
Farah Wehbe @farahwehbe92.bsky.social · 30/04/2026
Grateful to share our case report,Fatal Tea Tree Oil Intoxication,published in The American Journal of Medicine. The 1st documented fatal TTO ingestion case,complicated by multi-organ toxicity and AKI requiring hemodialysis. Thankful to my colleagues for their support. www.amjmed.com/article/S000...
amjmed.com
Fatal tea tree oil intoxication: A case report
A 35-year-old woman with schizophrenia, daily methamphetamine use, and a recent psychiatric admission for psychosis, presented after ingesting ∼ 30 mL of tea tree oil the night before, believing it wo...
010
Reposted by Farah Wehbe
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 11/03/2026
More pictures from the Ottawa #NephMadness party The fellows really did get quite animated for their second bracket 😂
123
Reposted by Farah Wehbe
Susan Thanabalasingam @susanthana.bsky.social · 22/04/2026
So proud that the TOH Nephrology Fellows be sharing the Canadian trophy with Queen’s for the Canadian Kidney Cup!!! 🫘🏆 @nephmadness.bsky.social @drflashheart.bsky.social #NephSky
033
Reposted by Farah Wehbe
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 07/01/2026
Cuffless BP review with @farahwehbe92.bsky.social - incoming HT fellow in Ottawa, with tables, and details of technology, devices and ongoing trials pubmed.ncbi.nlm.nih.gov/41460057/ thanks to @profdg.bsky.social for the invite!
pubmed.ncbi.nlm.nih.gov
Cuffless blood pressure in 2025: from promise to practice: a narrative review - PubMed
Cuffless wearables may be used as adjuncts to surface patterns and support engagement; diagnosis and treatment decisions must be confirmed with validated upper-arm measurements. A pragmatic "good-enough" checklist includes stable calibration over weeks, accuracy across dynamic states and subgroups, …
052
Farah Wehbe @farahwehbe92.bsky.social · 25/01/2026
Excited to share our review in #KIReports – a real milestone for me! #CKD at the Crossroads: From Failure to Future Therapies 1️⃣ Current & emerging CKD therapies 2️⃣ Why proven treatments are still underused 3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
163
Farah Wehbe @farahwehbe92.bsky.social · 25/01/2026
Honored to collaborate on this narrative review on cuffless blood pressure monitoring — a rapidly evolving space with huge clinical potential. Big thanks to @hswapnil.medsky.social for the opportunity!
131